The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China.

ABSTRACT:

Background

Antimicrobial resistance (AMR) is a serious global public health challenge. Physicians' over-prescription of antibiotics is a major contributor, and intravenous (IV) antibiotic use has been a particular concern in China. To address the rapid fallout of antibiotic overuse, the Chinese government has piloted a ban of IV antibiotics in the outpatient department (OD) with the exemption of paediatrics, emergency department (ED), and inpatient ward of secondary and tertiary hospitals in several provinces.

Methods

To assess the potential impact of the policy, we conducted a mixed-methods study including 1) interviews about the ban of IV antibiotic use with 68 stakeholders, covering patients, health workers, and policy-makers, from two cities and 2) a hospital case study

SUBMITTER: Wang X 

PROVIDER: S-EPMC7690204 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature